Hiroyuki Watanabe1,*, Olga Nosova1,*, Daniil Sarkisyan1, Marlene Storm Andersen2, Mengliang Zhang2,3, Linda Rorick-Kehn4, Fredrik Clausen5, Liliana Carvalho6, Nikolay Lukoyanov6, Kinga Gawel7, Jan Kehr8, Jens Schouenborg3, Niklas Marklund5 and Georgy Bakalkin1
1 Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden,
2 Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark,
3 Neuronano Research Center, Department of Experimental Medical Science, Lund University, Lund, Sweden,
4 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285 USA,
5 Department of Neuroscience, Neurosurgery, Uppsala University, Uppsala, Sweden,
6 Departamento de Biomedicina da Faculdade de Medicina da Universidade do Porto, Instituto de Investigação e Inovação em Saúde, Instituto de Biologia Molecular e Celular, Porto, Portugal,
7 Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Lublin, Poland, and
8 Department of Physiology and Pharmacology, Karolinska Institutet, Sweden
* Contributed equally to this work
Correspondence to :
Georgy Bakalkin
Department of Pharmaceutical Biosciences
751 24 Uppsala, Sweden